Meta
Phase I, II, and III Trials: What Each Actually Tests
Clinical trials happen in phases for a reason. An exploration of what Phase I, II, and III trials are designed to test—and what early results cannot yet establish.
Meta
Clinical trials happen in phases for a reason. An exploration of what Phase I, II, and III trials are designed to test—and what early results cannot yet establish.
Meta
A new study makes headlines, and the guidelines don't change. A closer look at why the lag between research and clinical recommendations is intentional—and what it takes for evidence to actually shift practice.
Meta
Scientific recommendations keep changing, and it feels like experts can't make up their minds. An exploration of why this happens, what separates genuine revision from flip-flopping, and how to interpret changing guidance more carefully.
Meta
Health studies often report clear results—but those results don’t apply equally to everyone. A closer look at how study design limits generalizability and how to read health claims more carefully.
Meta
‘Statistically significant’ sounds definitive—but it's not the same as large, important, or clinically meaningful. A closer look at what the term actually measures, why it's so often misunderstood, and how to read research claims more carefully.
Meta
Scientific headlines often hinge on a single study, promising clear answers. But individual studies are designed to answer narrow questions, not deliver universal truths. An exploration of why replication matters, how evidence accumulates, and how to read new research more carefully.
Meta
'Backed by science' sounds reassuring—but what does it actually mean? A closer look at how scientific evidence is built, interpreted, and often oversimplified.